These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 21762579

  • 1. Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
    William T, Menon J, Rajahram G, Chan L, Ma G, Donaldson S, Khoo S, Frederick C, Jelip J, Anstey NM, Yeo TW.
    Emerg Infect Dis; 2011 Jul; 17(7):1248-55. PubMed ID: 21762579
    [Abstract] [Full Text] [Related]

  • 2. Plasmodium knowlesi reinfection in human.
    Lau YL, Tan LH, Chin LC, Fong MY, Noraishah MA, Rohela M.
    Emerg Infect Dis; 2011 Jul; 17(7):1314-5. PubMed ID: 21762601
    [No Abstract] [Full Text] [Related]

  • 3. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate.
    Rajahram GS, Barber BE, William T, Menon J, Anstey NM, Yeo TW.
    Malar J; 2012 Aug 20; 11():284. PubMed ID: 22905799
    [Abstract] [Full Text] [Related]

  • 4. Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW.
    Grigg MJ, William T, Barber BE, Rajahram GS, Menon J, Schimann E, Wilkes CS, Patel K, Chandna A, Price RN, Yeo TW, Anstey NM.
    Clin Infect Dis; 2018 Jan 06; 66(2):229-236. PubMed ID: 29020373
    [Abstract] [Full Text] [Related]

  • 5. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
    Barber BE, William T, Grigg MJ, Menon J, Auburn S, Marfurt J, Anstey NM, Yeo TW.
    Clin Infect Dis; 2013 Feb 06; 56(3):383-97. PubMed ID: 23087389
    [Abstract] [Full Text] [Related]

  • 6. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
    Grigg MJ, William T, Menon J, Dhanaraj P, Barber BE, Wilkes CS, von Seidlein L, Rajahram GS, Pasay C, McCarthy JS, Price RN, Anstey NM, Yeo TW.
    Lancet Infect Dis; 2016 Feb 06; 16(2):180-188. PubMed ID: 26603174
    [Abstract] [Full Text] [Related]

  • 7. A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
    Grigg MJ, William T, Dhanaraj P, Menon J, Barber BE, von Seidlein L, Rajahram G, Price RN, Anstey NM, Yeo TW.
    BMJ Open; 2014 Aug 19; 4(8):e006005. PubMed ID: 25138814
    [Abstract] [Full Text] [Related]

  • 8. Intravascular haemolysis with haemoglobinuria in a splenectomized patient with severe Plasmodium knowlesi malaria.
    Barber BE, Grigg MJ, William T, Yeo TW, Anstey NM.
    Malar J; 2016 Sep 09; 15(1):462. PubMed ID: 27613607
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.
    Ukah M, Badejoko O, Ogunniyi S, Loto O, Aboderin O, Fatusi A.
    Int J Gynaecol Obstet; 2015 Oct 09; 131(1):41-4. PubMed ID: 26169336
    [Abstract] [Full Text] [Related]

  • 10. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM).
    Lancet; 2018 Apr 07; 391(10128):1378-1390. PubMed ID: 29606364
    [Abstract] [Full Text] [Related]

  • 11. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M, Khanthavong M, Lindegårdh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN.
    Clin Infect Dis; 2004 Oct 15; 39(8):1139-47. PubMed ID: 15486837
    [Abstract] [Full Text] [Related]

  • 12. Plasmodium knowlesi infection imported to Germany, January 2013.
    Orth H, Jensen BO, Holtfreter MC, Kocheril SJ, Mallach S, MacKenzie C, Müller-Stöver I, Henrich B, Imwong M, White NJ, Häussinger D, Richter J.
    Euro Surveill; 2013 Oct 03; 18(40):. PubMed ID: 24128698
    [Abstract] [Full Text] [Related]

  • 13. Artemether-lumefantrine for uncomplicated malaria: a systematic review.
    Omari AA, Gamble C, Garner P.
    Trop Med Int Health; 2004 Feb 03; 9(2):192-9. PubMed ID: 15040555
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
    Sirima SB, Ogutu B, Lusingu JPA, Mtoro A, Mrango Z, Ouedraogo A, Yaro JB, Onyango KO, Gesase S, Mnkande E, Ngocho JS, Ackermann I, Aubin F, Vanraes J, Strub N, Carn G.
    Lancet Infect Dis; 2016 Oct 03; 16(10):1123-1133. PubMed ID: 27430374
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial.
    Kayentao K, Doumbo OK, Pénali LK, Offianan AT, Bhatt KM, Kimani J, Tshefu AK, Kokolomami JH, Ramharter M, de Salazar PM, Tiono AB, Ouédraogo A, Bustos MD, Quicho F, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L.
    Malar J; 2012 Oct 31; 11():364. PubMed ID: 23113947
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Sagara I, Diallo A, Kone M, Coulibaly M, Diawara SI, Guindo O, Maiga H, Niambele MB, Sissoko M, Dicko A, Djimde A, Doumbo OK.
    Am J Trop Med Hyg; 2008 Nov 31; 79(5):655-61. PubMed ID: 18981499
    [Abstract] [Full Text] [Related]

  • 19. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
    Owusu-Agyei S, Asante KP, Owusu R, Adjuik M, Amenga-Etego S, Dosoo DK, Gyapong J, Greenwood B, Chandramohan D.
    PLoS One; 2008 Jun 25; 3(6):e2530. PubMed ID: 18575626
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Pyronaridine-artesunate Study Team.
    Lancet; 2010 Apr 24; 375(9724):1457-67. PubMed ID: 20417857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.